Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00098579
What this trial is testing

Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Stromal TumorRecurrent Adult Soft Tissue SarcomaStage IV Adult Soft Tissue Sarcoma
National Cancer Institute (NCI) 36
Large-scale testing (Phase 3)Ended earlyNCT02009423
What this trial is testing

Masitinib in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence

Who this might be right for
Gastro-Intestinal Stromal Tumour
AB Science 7
Early research (Phase 1)Study completedNCT00069940
What this trial is testing

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Stromal TumorSarcoma
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Early research (Phase 1)Study completedNCT01738139
What this trial is testing

Ipilimumab and Imatinib Mesylate in Advanced Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmC-KIT Tyrosine Kinase Protein OverexpressionClinical Stage IV Cutaneous Melanoma AJCC v8+6 more
M.D. Anderson Cancer Center 68
Not applicableUnknownNCT02763748
What this trial is testing

The Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
First Affiliated Hospital Xi'an Jiaotong University 120
Testing effectiveness (Phase 2)Study completedNCT01110668
What this trial is testing

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor
Novartis Pharmaceuticals 2
Large-scale testing (Phase 3)UnknownNCT02576080
What this trial is testing

Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index

Who this might be right for
Gastrointestinal Stromal Tumor
Assistance Publique Hopitaux De Marseille 80
Not applicableStudy completedNCT04599660
What this trial is testing

Study in Low Risk Gastrointestinal Stromal Tumor (GISTs)

Who this might be right for
GIST
Italian Sarcoma Group 700
Not applicableLooking for participantsNCT07405125
What this trial is testing

Safety of Robotic Surgery for GISTs at Special Anatomic Sites

Who this might be right for
Gastrointenstinal Stromal Tumor (GIST)
The First Affiliated Hospital with Nanjing Medical University 182
Testing effectiveness (Phase 2)Study completedNCT00464620
What this trial is testing

Trial of Dasatinib in Advanced Sarcomas

Who this might be right for
RhabdomyosarcomaMalignant Peripheral Nerve Sheath TumorsChondrosarcoma+7 more
Sarcoma Alliance for Research through Collaboration 366
Testing effectiveness (Phase 2)Study completedNCT00005862
What this trial is testing

SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas

Who this might be right for
Gastrointestinal Stromal TumorSarcoma
National Cancer Institute (NCI) 60
Not applicableUnknownNCT05440357
What this trial is testing

Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study

Who this might be right for
Gastrointestinal Stromal Tumors
Xinhua Zhang, MD 100
Testing effectiveness (Phase 2)Study completedNCT00171912
What this trial is testing

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Who this might be right for
Hypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more
Novartis Pharmaceuticals 38
Early research (Phase 1)Study completedNCT00135005
What this trial is testing

Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 59
Not applicableStudy completedNCT03722056
What this trial is testing

Laparoscopic Management of Gastrointestinal Stromal Tumor of Stomach

Who this might be right for
Gastric GISTSubmucosal Tumor of Stomach
GEM Hospital & Research Center 42
Testing effectiveness (Phase 2)Study completedNCT02712112
What this trial is testing

Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs

Who this might be right for
Gastrointestinal Stromal Tumors (GISTs)
Asan Medical Center 51
Testing effectiveness (Phase 2)UnknownNCT01389583
What this trial is testing

AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients

Who this might be right for
Gastrointestinal Stromal Tumor
National Health Research Institutes, Taiwan 25
Testing effectiveness (Phase 2)Study completedNCT03556384
What this trial is testing

Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal TumorsSdhGIST+1 more
Adam Burgoyne, MD, PhD 23
Large-scale testing (Phase 3)Ended earlyNCT00956072
What this trial is testing

Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate

Who this might be right for
Gastrointestinal Stromal Tumor
European Organisation for Research and Treatment of Cancer - EORTC 12
Next Page